Skip to main content

A Multicenter Phase I/Ib open label dose escalation study of ABBV-399, and antibody drug conjugate, in subjects with advanced solid tumors.

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

March 1, 2014

End Date

February 27, 2023
 

Administered By

Duke Cancer Institute

Awarded By

AbbVie Inc.

Start Date

March 1, 2014

End Date

February 27, 2023